Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001628280-23-039300

Chief Executive Officer returned 4,604 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virnich Daniel Chief Executive Officer 2023-11-14 Returned to the company −4,604 $2.39 $10,981 733,925 D
Loading xslF345X05/wk-form4_1700168164.xml…